Secondary outcomes are seizure frequency and psychological distress ( anxiety and depression ) , perceived impact of epilepsy , adherence to medication , management of adverse effects from medication , and improved self-efficacy in management ( mastery/control ) of epilepsy.Within the trial there will be a nested qualitative study to explore users ' views of the intervention , including barriers to participation and the perceived benefits of the intervention .